Market Value1,018,174,480
Total Holdings63
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TERN / Terns Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
PRLD / Prelude Therapeutics Incorporated
EDIT / Editas Medicine, Inc.
ZTS / Zoetis Inc.
BMRN / BioMarin Pharmaceutical Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
SYRS / Syros Pharmaceuticals, Inc.
ESTA / Establishment Labs Holdings Inc.
BLUE / bluebird bio, Inc.
ANRO / Alto Neuroscience, Inc.
KZR / Kezar Life Sciences, Inc.
TMDX / TransMedics Group, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
HYPR / Hyperfine, Inc.
ARVN / Arvinas, Inc. Call
ORKA / Oruka Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
CNTX / Context Therapeutics Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
RGNX / REGENXBIO Inc.
NGNE / Neurogene Inc.
INSM / Insmed Incorporated
RVMD / Revolution Medicines, Inc.
TMO / Thermo Fisher Scientific Inc.
BSX / Boston Scientific Corporation
XENE / Xenon Pharmaceuticals Inc.
ISRG / Intuitive Surgical, Inc.
NTRA / Natera, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
CATX / Perspective Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
QURE / uniQure N.V.
DHR / Danaher Corporation
IMUX / Immunic, Inc.
THC / Tenet Healthcare Corporation
HUM / Humana Inc.
AXSM / Axsome Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
CMAXQ / CareMax, Inc.
TIL / Instil Bio, Inc.
IMVT / Immunovant, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
CGEM / Cullinan Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
CYBN / Cybin Inc.
IDYA / IDEAYA Biosciences, Inc.
ABBV / AbbVie Inc.
GKOS / Glaukos Corporation
KYMR / Kymera Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
ACHC / Acadia Healthcare Company, Inc.
UNH / UnitedHealth Group Incorporated
VERA / Vera Therapeutics, Inc.
SGRY / Surgery Partners, Inc.
NBIX / Neurocrine Biosciences, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
JANX / Janux Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
CGON / CG Oncology, Inc.
AVTR / Avantor, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
BRKR / Bruker Corporation
RARE / Ultragenyx Pharmaceutical Inc.
EXAS / Exact Sciences Corporation
BHVN / Biohaven Ltd.
ILMN / Illumina, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
PRVA / Privia Health Group, Inc.
ARVN / Arvinas, Inc.
JAZZ / Jazz Pharmaceuticals plc
KZR / Kezar Life Sciences, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
DXCM / DexCom, Inc.
BPMC / Blueprint Medicines Corporation
BMY / Bristol-Myers Squibb Company
APGE / Apogee Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
PRME / Prime Medicine, Inc.
KPTI / Karyopharm Therapeutics Inc.
IMNM / Immunome, Inc.
INCY / Incyte Corporation
NMRA / Neumora Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc. Call